As Coca Cola Co (KO) Share Value Rose, Shareholder Shelton Capital Management Has Trimmed Holding by $708,382; Perceptive Advisors Raised Position in Adma Biologics (ADMA) by $10.80 Million as Share Price Rose

The Coca-Cola Company (NYSE:KO) Logo

Shelton Capital Management decreased its stake in Coca Cola Co (KO) by 24.76% based on its latest 2018Q2 regulatory filing with the SEC. Shelton Capital Management sold 16,474 shares as the company’s stock rose 4.66% with the market. The institutional investor held 50,071 shares of the beverages (production and distribution) company at the end of 2018Q2, valued at $2.20M, down from 66,545 at the end of the previous reported quarter. Shelton Capital Management who had been investing in Coca Cola Co for a number of months, seems to be less bullish one the $208.21B market cap company. The stock decreased 1.34% or $0.67 during the last trading session, reaching $48.92. About 3.62 million shares traded. The Coca-Cola Company (NYSE:KO) has declined 1.03% since December 6, 2017 and is downtrending. It has underperformed by 16.65% the S&P500. Some Historical KO News: 07/05/2018 – IFF to buy Israel’s Frutarom for $7.1 bln, nearing top spot; 06/03/2018 – Coca-Cola to launch alcoholic drink in Japan; 30/05/2018 – Ben Shanley, Senior Vice President, National Foodservice Operations at Coca-Cola North America, Receives IFMA’s Distinguished Foodservice Executive Award; 09/03/2018 – COCA-COLA TO REFRANCHISE COCA-COLA REFRESHMENTS CANADA; 24/04/2018 – Coca-Cola 1Q Europe Unit Case Volume Up 4%; 26/04/2018 – COCA-COLA CO KO.N SETS REGULAR QUARTERLY DIVIDEND OF $0.39/SHR; 17/04/2018 – COCA-COLA CO KO.N : GOLDMAN SACHS RAISES TO NEUTRAL; 08/03/2018 – COCA-COLA BEVERAGES FLA. GETS $325M SR UNSEC REVOLVING CDT LINE; 20/03/2018 – COCA-COLA HBC ROMANIA NAMES JOVAN RADOSAVLJEVIC GENERAL MANAGER; 26/04/2018 – S&P Lowers All Coca-Cola Ratings, Including the Corporate Credit Rating One Notch to ‘A+’

Perceptive Advisors Llc increased its stake in Adma Biologics Inc (ADMA) by 70.66% based on its latest 2018Q2 regulatory filing with the SEC. Perceptive Advisors Llc bought 2.70M shares as the company’s stock rose 30.69% with the market. The hedge fund held 6.52 million shares of the biological products (no diagnostic substances) company at the end of 2018Q2, valued at $29.41 million, up from 3.82 million at the end of the previous reported quarter. Perceptive Advisors Llc who had been investing in Adma Biologics Inc for a number of months, seems to be bullish on the $229.90M market cap company. The stock increased 0.40% or $0.02 during the last trading session, reaching $4.96. About 32,727 shares traded. ADMA Biologics, Inc. (NASDAQ:ADMA) has risen 68.73% since December 6, 2017 and is uptrending. It has outperformed by 53.11% the S&P500. Some Historical ADMA News: 14/05/2018 – ADMA BIOLOGICS INC – BPC WILL WAIVE AND TERMINATE ALL RIGHTS TO NAME A DIRECTOR AND OBSERVER TO ADMA’S BOARD OF DIRECTORS; 14/05/2018 – ADMA Biologics: Total Outstanding Common Stk Reduced by Approximately 19%; 16/05/2018 – ADMA Biologics Granted U.S. Patent for Treating Respiratory Infections; 14/05/2018 – ADMA BIOLOGICS – AT MARCH 31, 2018, ADMA HAD CASH AND CASH EQUIVALENTS OF $26.1 MLN, AS COMPARED TO $43.1 MLN AT DECEMBER 31, 2017; 22/04/2018 DJ ADMA Biologics Inc, Inst Holders, 1Q 2018 (ADMA); 16/05/2018 – ADMA BIOLOGICS INC – UNITED STATES PATENT AND TRADEMARK OFFICE ISSUED PATENT COVERING METHODS OF TREATING RESPIRATORY INFECTIONS; 24/04/2018 – ADMA BIOLOGICS INC – COMPLETED MANUFACTURING, RELEASE AND HAS MADE COMMERCIAL SALES OF ITS FIRST BATCH OF NABI-HB; 14/05/2018 – ADMA Biologics: Biotest Will Waive, Terminate All Rights to Name a Director to ADMA’s Bd of Directors; 14/05/2018 – ADMA BIOLOGICS – ADMA WILL TERMINATE RIGHTS TO REPURCHASE 2 ADMA BIOCENTERS WHICH CO HAD PREVIOUSLY AGREED TO TRANSFER TO BPC ON JANUARY 1, 2019; 14/05/2018 – ADMA Biologics 1Q Loss/Shr 39c

Among 6 analysts covering ADMA Biologics (NASDAQ:ADMA), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. ADMA Biologics had 14 analyst reports since September 9, 2015 according to SRatingsIntel. Raymond James downgraded the stock to “Market Perform” rating in Monday, August 1 report. The rating was downgraded by Maxim Group on Monday, August 1 to “Hold”. Maxim Group upgraded the stock to “Buy” rating in Monday, January 23 report. The company was maintained on Friday, October 12 by Raymond James. The rating was initiated by Raymond James with “Strong Buy” on Wednesday, September 9. The stock has “Buy” rating by Maxim Group on Thursday, September 17. The firm has “Outperform” rating given on Tuesday, November 14 by Raymond James. Ladenburg maintained ADMA Biologics, Inc. (NASDAQ:ADMA) on Wednesday, June 13 with “Buy” rating. The stock of ADMA Biologics, Inc. (NASDAQ:ADMA) earned “Buy” rating by Maxim Group on Thursday, July 26. The stock of ADMA Biologics, Inc. (NASDAQ:ADMA) earned “Buy” rating by Maxim Group on Wednesday, June 7.

More notable recent ADMA Biologics, Inc. (NASDAQ:ADMA) news were published by: Benzinga.com which released: “Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates – Benzinga” on November 30, 2018, also Streetinsider.com with their article: “After-Hours Stock Movers 06/07: (ZUMZ) (DOCU) (SFIX) Higher; (MVIS) (ITI) (ADMA) Lower (more…) – StreetInsider.com” published on June 07, 2018, Globenewswire.com published: “ADMA Biologics Resubmits Biologics License Application for RI-002 – GlobeNewswire” on October 01, 2018. More interesting news about ADMA Biologics, Inc. (NASDAQ:ADMA) were released by: Benzinga.com and their article: “Benzinga’s Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen’s Beat-And-Raise Quarter – Benzinga” published on July 27, 2018 as well as Seekingalpha.com‘s news article titled: “ADMA Biologics: Can We Trust This ~$3 Biotech Stock Again? – Seeking Alpha” with publication date: November 27, 2017.

Perceptive Advisors Llc, which manages about $2.09 billion and $3.82 billion US Long portfolio, decreased its stake in Teladoc Inc by 325,000 shares to 195,000 shares, valued at $11.32 million in 2018Q2, according to the filing. It also reduced its holding in Abiomed Inc (NASDAQ:ABMD) by 295,803 shares in the quarter, leaving it with 36,646 shares, and cut its stake in Akebia Therapeutics Inc (NASDAQ:AKBA).

Investors sentiment increased to 3.67 in 2018 Q2. Its up 0.81, from 2.86 in 2018Q1. It increased, as 9 investors sold ADMA shares while 3 reduced holdings. 27 funds opened positions while 17 raised stakes. 46.43 million shares or 199.18% more from 15.52 million shares in 2018Q1 were reported. Consonance Mgmt Limited Partnership owns 4.25 million shares. Bancshares Of Ny Mellon Corporation holds 0% of its portfolio in ADMA Biologics, Inc. (NASDAQ:ADMA) for 54,828 shares. Millennium Mgmt Limited holds 0% or 229,416 shares. Architects Incorporated, a New Jersey-based fund reported 15,000 shares. Ameritas Investment Prtn reported 0% of its portfolio in ADMA Biologics, Inc. (NASDAQ:ADMA). Raymond James Svcs Advsr reported 0% in ADMA Biologics, Inc. (NASDAQ:ADMA). Prelude Cap Management Ltd Liability has invested 0.02% in ADMA Biologics, Inc. (NASDAQ:ADMA). Natl Bank Of Montreal Can accumulated 134 shares. Aisling Cap Limited Co reported 3.61M shares or 2.14% of all its holdings. Moreover, Raymond James & Assoc has 0% invested in ADMA Biologics, Inc. (NASDAQ:ADMA) for 21,320 shares. California-based Wells Fargo Mn has invested 0% in ADMA Biologics, Inc. (NASDAQ:ADMA). Tiaa Cref Investment Ltd Liability Corporation invested in 29,011 shares. Schwab Charles Investment Mgmt stated it has 0% of its portfolio in ADMA Biologics, Inc. (NASDAQ:ADMA). Ardsley Advisory Ptnrs holds 0.05% or 80,000 shares. Raymond James Na reported 17,792 shares or 0.01% of all its holdings.

Shelton Capital Management, which manages about $1.01 billion and $1.61 billion US Long portfolio, upped its stake in Terraform Pwr Inc by 45,000 shares to 90,000 shares, valued at $1.05M in 2018Q2, according to the filing. It also increased its holding in Intel Corp (NASDAQ:INTC) by 149,614 shares in the quarter, for a total of 656,639 shares, and has risen its stake in Trex Co Inc (NYSE:TREX).

Among 23 analysts covering Coca-Cola (NYSE:KO), 14 have Buy rating, 0 Sell and 9 Hold. Therefore 61% are positive. Coca-Cola had 82 analyst reports since July 21, 2015 according to SRatingsIntel. The company was maintained on Thursday, May 17 by Citigroup. As per Friday, February 5, the company rating was upgraded by Susquehanna. The stock of The Coca-Cola Company (NYSE:KO) has “Outperform” rating given on Tuesday, November 14 by Wells Fargo. The rating was maintained by RBC Capital Markets with “Outperform” on Thursday, March 10. Wells Fargo downgraded the shares of KO in report on Thursday, January 19 to “Market Perform” rating. The rating was maintained by Morgan Stanley with “Equal-Weight” on Thursday, October 26. Deutsche Bank maintained the shares of KO in report on Friday, September 25 with “Buy” rating. Susquehanna maintained The Coca-Cola Company (NYSE:KO) rating on Tuesday, March 15. Susquehanna has “Neutral” rating and $39 target. Barclays Capital upgraded the stock to “Overweight” rating in Thursday, May 17 report. Credit Suisse maintained the stock with “Buy” rating in Monday, March 12 report.

Analysts await The Coca-Cola Company (NYSE:KO) to report earnings on February, 15. They expect $0.42 earnings per share, up 7.69% or $0.03 from last year’s $0.39 per share. KO’s profit will be $1.79B for 29.12 P/E if the $0.42 EPS becomes a reality. After $0.58 actual earnings per share reported by The Coca-Cola Company for the previous quarter, Wall Street now forecasts -27.59% negative EPS growth.

Since July 25, 2018, it had 0 insider purchases, and 13 sales for $22.51 million activity. HAYS ED had sold 91,000 shares worth $4.43 million. $2.60M worth of The Coca-Cola Company (NYSE:KO) was sold by MURPHY JOHN. $729,768 worth of stock was sold by LONG ROBERT EDWARD on Monday, November 5. On Wednesday, October 24 the insider DINKINS JAMES L sold $411,000. $1.20M worth of The Coca-Cola Company (NYSE:KO) shares were sold by RIVERA ALFREDO. MANN JENNIFER K had sold 15,100 shares worth $761,040 on Monday, November 19.

More notable recent The Coca-Cola Company (NYSE:KO) news were published by: Investingnews.com which released: “Cannabis M&A Advisor: US Deals Coming for Canadian Companies – Investing News Network” on December 06, 2018, also Bizjournals.com with their article: “J.H. Whitney reportedly selling pet food company – New York Business Journal” published on December 05, 2018, Bizjournals.com published: “Report: Former Coca-Cola exec won’t launch 2020 presidential campaign – Atlanta Business Chronicle” on December 05, 2018. More interesting news about The Coca-Cola Company (NYSE:KO) were released by: Fool.com and their article: “Stock Market Power Rankings: Microsoft Parties Like Its 2002 – The Motley Fool” published on December 02, 2018 as well as Benzinga.com‘s news article titled: “Wal-Mart Stores, Inc. (NYSE:WMT), Coca-Cola Company (The) (NYSE:KO) – Direxion Unveils Four Leveraged Consumer ETFs – Benzinga” with publication date: November 30, 2018.

Investors sentiment increased to 0.74 in Q2 2018. Its up 0.05, from 0.69 in 2018Q1. It increased, as 57 investors sold KO shares while 663 reduced holdings. 122 funds opened positions while 412 raised stakes. 2.70 billion shares or 0.70% less from 2.72 billion shares in 2018Q1 were reported. Moreover, Independent Invsts has 0.87% invested in The Coca-Cola Company (NYSE:KO) for 50,431 shares. Steinberg Global Asset Mngmt holds 9,803 shares. Yorktown Management & Rech stated it has 15,000 shares or 0.19% of all its holdings. Utah Retirement Sys reported 708,580 shares stake. Interocean Cap Limited Liability Com has invested 0.27% of its portfolio in The Coca-Cola Company (NYSE:KO). Signaturefd holds 3.23% or 660,147 shares in its portfolio. Prio Wealth Partnership holds 0.52% or 239,920 shares. Altfest L J & Communication holds 0.32% or 19,885 shares. Matrix Asset Ny invested in 38,530 shares or 0.28% of the stock. Cutter And Brokerage Incorporated reported 0.1% of its portfolio in The Coca-Cola Company (NYSE:KO). Weatherly Asset Limited Partnership holds 0.22% or 21,307 shares in its portfolio. Windsor Ltd Liability Com owns 35,284 shares. Cornerstone Advisors, a Washington-based fund reported 16,041 shares. Nelson Roberts Investment Advsrs Limited Liability Corp has 0.14% invested in The Coca-Cola Company (NYSE:KO). Mutual Of Omaha National Bank Wealth Management stated it has 1.43% of its portfolio in The Coca-Cola Company (NYSE:KO).

The Coca-Cola Company (NYSE:KO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.